Lamivudine therapy for chronic hepatitis B in children: a meta-analysis

BACKGROUND: Currently, there is no consensus on the effects and safety of lamivudine therapy for chronic hepatitis B (CHB) in children. METHOD: Both English and Chinese databases were searched comprehensively. An odds ratio (OR) and a standard mean difference (SMD) were used to assess the effects an...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Aoran, Jiang, Xiaoyan, Ren, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610965/
https://www.ncbi.nlm.nih.gov/pubmed/31272463
http://dx.doi.org/10.1186/s12985-019-1193-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610965/
https://www.ncbi.nlm.nih.gov/pubmed/31272463
http://dx.doi.org/10.1186/s12985-019-1193-x

Ejemplares similares